By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CRISPR Therapeutics 

675 West Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-580-9212 Fax: n/a


SEARCH JOBS

CRISPR Therapeutics is a leading gene editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing platform. CRISPR is a revolutionary technology that allows for precise, directed changes to genomic DNA. The Company’s multi-disciplinary team of world-class researchers and drug developers is working on a number of wholly-owned programs to treat serious diseases with high unmet need.

YEAR FOUNDED:

November 2013

LEADERSHIP:

Founders: Rodger Novak, Emmanuelle Charpentier, Shaun Foy

Scientific Founders: Chad Cowan, Daniel Anderson, Stephen Elledge, Craig Mello, Matthew Porteus

CEO and Co-founder: Rodger Novak

CFO: Marc Becker

CSO (Scientific): Sven Ante (Bill) Lundberg

JOBS:

Please click here for CRISPR Therapeutics job opportunities.

FOLLOW CRISPR THERAPEUTICS:






Key Statistics


Email: info@crisprtx.com
Ownership: Public

Web Site: CRISPR
Employees:
Symbol: CRSP
 









Company News
CRISPR (CRSP)'s Surprisingly Low IPO… Why Are Investors Discouraged? 10/21/2016 6:53:29 AM
CRISPR (CRSP) IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year 10/19/2016 5:43:31 AM
Gene Editing Phenom CRISPR (CRSP) Files for $90 Million IPO 9/12/2016 6:10:31 AM
Bayer (BAY) and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area 8/19/2016 5:59:17 AM
CRISPR Gene Editing Reveals New Therapeutic Approach For Sickle Cell Disease 8/15/2016 8:47:46 AM
CRISPR Reels in Another $38 Million Series B Financing 6/24/2016 6:02:28 AM
CRISPR And Anagenesis Biotechnologies Announce Strategic In-Licensing And Collaboration Agreement To Develop CRISPR/Cas9-Based Cell Therapies For Muscle Diseases 6/8/2016 8:13:12 AM
CRISPR Adds Pablo J. Cagnoni, M.D., To Board Of Directors And Names Tony Coles, M.D., Chairman Of The Board To Enhance Drug Development And Commercialization Expertise 3/17/2016 10:38:15 AM
CRISPR Appoints Former rEVO Biologics Exec as CFO 3/10/2016 5:54:32 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
123
//-->